Patents by Inventor Kurt C. Gish

Kurt C. Gish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Publication number: 20030118509
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal cancer are described.
    Type: Application
    Filed: September 24, 2002
    Publication date: June 26, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: David H. Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Publication number: 20030108926
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Application
    Filed: October 3, 2002
    Publication date: June 12, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
    Patent number: 6566502
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast and/or colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast and/or colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast and/or colorectal cancer are described.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: May 20, 2003
    Assignee: Eos Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Uses of PBH1 in the diagnosis and therapeutic treatment of prostate cancer
    Publication number: 20030087245
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of prostate cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate prostate cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in prostate and other cancers are described.
    Type: Application
    Filed: January 24, 2002
    Publication date: May 8, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: Kurt C. Gish, David H. Mack, Daniel Afar
  • Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
    Publication number: 20030077568
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Application
    Filed: August 14, 2001
    Publication date: April 24, 2003
    Inventors: Kurt C. Gish, David H. Mack, Keith E. Wilson
  • Mammalian chemokine reagents
    Publication number: 20030018167
    Abstract: Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: January 3, 2002
    Publication date: January 23, 2003
    Applicant: Schering Corporation, a New Jersey corporation
    Inventors: Wei Wang, Kurt C. Gish, Thomas J. Schall, Alain Vicari, Albert Zlotnik
  • Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Patent number: 6455668
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal cancer are described.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: September 24, 2002
    Assignee: Eos Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Publication number: 20020102544
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal cancer are described.
    Type: Application
    Filed: December 8, 2000
    Publication date: August 1, 2002
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
    Publication number: 20020076707
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast and/or colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast and/or colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast and/or colorectal cancer are described.
    Type: Application
    Filed: April 6, 2001
    Publication date: June 20, 2002
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosis of prostate cancer and/or breast cancer, compositions, and methods of screening for prostate cancer and /or breast cancer modulators
    Publication number: 20020068036
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of prostate cancer and/or breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate prostate cancer and/or breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in prostate cancer, breast cancer and other cancers are described.
    Type: Application
    Filed: April 30, 2001
    Publication date: June 6, 2002
    Applicant: EOS BIOTECHNOLOGY, INC.
    Inventors: Peter Hevezi, David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Publication number: 20020042067
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal cancer are described.
    Type: Application
    Filed: May 8, 2001
    Publication date: April 11, 2002
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
    Publication number: 20020006616
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast cancer are described.
    Type: Application
    Filed: December 21, 2000
    Publication date: January 17, 2002
    Inventors: Kurt C. Gish, David Mack
  • Methods of diagnosis of colorectal cancer and methods of screening for colorectal cancer modulators
    Patent number: 6316272
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: November 13, 2001
    Assignee: EOS Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
    Patent number: 6294343
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in colorectal and other cancers are described.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: September 25, 2001
    Assignee: EOS Biotechnology, Inc.
    Inventors: David Mack, Kurt C. Gish, Keith E. Wilson
  • Intracellular regulatory molecules; related reagents
    Patent number: 6274312
    Abstract: Purified genes encoding intracellular regulatory molecules from a human, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding these molecules are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: December 10, 1997
    Date of Patent: August 14, 2001
    Assignee: Schering Corporation
    Inventors: Kurt C. Gish, Wolfgang Seghezzi, Frances Shanahan, Emma M. Lees, Terrill K. McClanahan